IN2014MU00495A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MU00495A IN2014MU00495A IN495MU2014A IN2014MU00495A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A IN 495MU2014 A IN495MU2014 A IN 495MU2014A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutical compositions
- abstract
- cancer
- preparing
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2015/050384 WO2015121649A1 (fr) | 2014-02-12 | 2015-02-12 | Composition pharmaceutique contenant du vémurafénib |
ZA2015/00995A ZA201500995B (en) | 2014-02-12 | 2015-02-12 | Low dose pharmaceutical composition |
IN495MU2014 IN2014MU00495A (fr) | 2014-02-12 | 2015-02-12 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN495MU2014 IN2014MU00495A (fr) | 2014-02-12 | 2015-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MU00495A true IN2014MU00495A (fr) | 2015-09-25 |
Family
ID=52544516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN495MU2014 IN2014MU00495A (fr) | 2014-02-12 | 2015-02-12 |
Country Status (3)
Country | Link |
---|---|
IN (1) | IN2014MU00495A (fr) |
WO (1) | WO2015121649A1 (fr) |
ZA (1) | ZA201500995B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7300394B2 (ja) | 2017-01-17 | 2023-06-29 | ヘパリジェニックス ゲーエムベーハー | 肝再生の促進又は肝細胞死の低減もしくは予防のためのプロテインキナーゼ阻害 |
WO2019008487A1 (fr) * | 2017-07-05 | 2019-01-10 | Novartis Ag | Nouvelle composition pharmaceutique |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR078033A1 (es) * | 2009-04-03 | 2011-10-12 | Plexxikon Inc | Una dispersion solida, que contiene al compuesto {3-[5-(4-(cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico, composiciones y formulaciones que comprenden a dicha dispersion solida; metodos para fabricar dicha dispersion solida, formas 1 y 2 de |
US20130172375A1 (en) * | 2011-12-13 | 2013-07-04 | Hoffmann-La Roche Inc. | Pharmaceutical composition |
-
2015
- 2015-02-12 IN IN495MU2014 patent/IN2014MU00495A/en unknown
- 2015-02-12 WO PCT/GB2015/050384 patent/WO2015121649A1/fr active Application Filing
- 2015-02-12 ZA ZA2015/00995A patent/ZA201500995B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201500995B (en) | 2015-12-23 |
WO2015121649A1 (fr) | 2015-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023008693A (es) | Polinucleotidos moduladores. | |
MX2020012165A (es) | Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cancer. | |
PH12016501898B1 (en) | Quinoxaline derivatives useful as fgfr kinase modulators | |
MX2020003702A (es) | Ciclopropilaminas como inhibidores de desmetilasa especifica de lisina 1 (lsd1). | |
MX2018008052A (es) | Inhibidores de desmetilasa especifica de lisina 1 (lsd1). | |
PH12016501601A1 (en) | Cyclopropylamines as lsd1 inhibitors | |
MX2018007421A (es) | Compuestos inhibidores de quinasa de union a tank. | |
MX2016015862A (es) | Compuestos inhibidores de la cinasa de union a tank. | |
TW201613860A (en) | Cyclopropylamines as LSD1 inhibitors | |
TW201613886A (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
MX2016010216A (es) | Composiciones farmaceuticas solidas de antagonistas de los receptores de androgenos. | |
IN2014MU00303A (fr) | ||
PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
PH12017500853A1 (en) | Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases | |
IN2014CH00840A (fr) | ||
IN2014MU00916A (fr) | ||
IN2014MU00495A (fr) | ||
GEP201706795B (en) | Hexahydrofuropyrroles as pde1 inhibitors | |
PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs | |
MX2017005669A (es) | Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos. | |
EA201691620A1 (ru) | Циклопропиламины в качестве ингибиторов lsd1 |